Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
sPIF in Autoimmune Hepatitis
NCT02239562Phase 1Completed
- Start
- Nov 2014
- Primary completion
- Apr 2016
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of synthetic preimplantation factor in autoimmune hepatitis (AIH) (6 arms). Primary endpoint: Safety and Tolerability at 29 days. Started Nov 2014; status: completed.
02
Drugs
synthetic preimplantation factor
03
Conditions
autoimmune hepatitis (AIH)
Beyond the preview
Go deeper on NCT02239562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02239562.